COMPANY

Koronis Biomedical Technologies

Location: Minneapolis, MN · source · Oct 12, 2026

Profile checked Oct 10, 2026

Keywords: Copd Asthma Acute Exacerbation of COPD Cystic Fibrosis Inhaler Trainer System Executive Function Intervention

Funding and NIH signals

NIH award NIH awarded $1.1M (SBIR Phase II 5R44DK127631-05, continuation, notice Aug 11, 2026). NIH RePORTER 5R44DK127631-05 (Aug 11, 2026)
Evidence (1 event)
- Aug 11, 2026 · NIH RePORTER 5R44DK127631-05
  Organization: KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT; City/State: Minneapolis, MN; Project number: 5R44DK127631-05; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-11; FY total cost (award amount): 1099700; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Kidney Support in Pediatric Patients using an Ultrafiltration Device; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Dec 1, 2026 Trial start Not phased (device or behavioral study): Portable Positive Pressure Therapy Device source ↗
Aug 11, 2026 Grant Government grant — SBIR: $1.1M (annual award, as published), announced Aug 11, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Oct 9, 2025 Trial start Not phased (device or behavioral study): Inhaler Trainer Efficacy Study source ↗
Sep 5, 2025 Grant Government grant — SBIR: $1.1M (annual award, as published), announced Sep 5, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 29, 2025 Grant Government grant — SBIR: $389,019 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 14, 2025 Grant Government grant — SBIR: $499,921 (annual award, as published), announced Aug 14, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Mar 10, 2025 Trial start Not phased (device or behavioral study): Parent-Child EF Intervention source ↗
Sep 1, 2020 Trial start Not phased (device or behavioral study): Cystic Fibrosis Remote Monitoring System source ↗

Aug 1, 2027 (ESTIMATED) · Not phased · Portable Positive Pressure Therapy Device · NCT04452851

Estimated primary completion per ClinicalTrials.gov. Dates move.

Last 2 years.

Aug 11, 2026 Government grant — SBIR: $1.1M (annual award, as published), announced Aug 11, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
Sep 5, 2025 Government grant — SBIR: $1.1M (annual award, as published), announced Sep 5, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 29, 2025 Government grant — SBIR: $389,019 (annual award, as published), announced Aug 29, 2025. Agency: NIH/NIDDK. Source: government award database. source ↗
Aug 14, 2025 Government grant — SBIR: $499,921 (annual award, as published), announced Aug 14, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06461403	Inhaler Trainer Efficacy Study	Not phased (device or behavioral study)	Completed	Oct 9, 2025	Apr 28, 2026 (actual)
NCT06924307	Parent-Child EF Intervention	Not phased (device or behavioral study)	Recruiting	Mar 10, 2025	Feb 28, 2026 (estimated)
NCT04452851	Portable Positive Pressure Therapy Device	Not phased (device or behavioral study)	Not yet recruiting	Dec 1, 2026	Aug 1, 2027 (estimated)
NCT04453358	Cystic Fibrosis Remote Monitoring System	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	Sep 1, 2020	Jul 31, 2021 (estimated)